In the BioHarmony Drug Report Database

"Preview" Icon

Cytarabine

Cytarabine, Depocyt, Vyxeos (cytarabine) is a small molecule pharmaceutical. Cytarabine was first approved as Cytarabine on 1982-01-01. It is used to treat leukemia, lymphoma, and meningeal neoplasms in the USA. It has been approved in Europe to treat myeloid leukemia acute.

 

Trade Name

 

Vyxeos liposomal, known as Vyxeos
 

Common Name

 

cytarabine
 

ChEMBL ID

 

CHEMBL803
 

Indication

 

leukemia, lymphoma, meningeal neoplasms, myeloid leukemia acute
 

Drug Class

 

Antineoplastics (arabinofuranosyl derivatives)

Image (chem structure or protein)

Cytarabine structure rendering